NEW YORK (GenomeWeb News) - Bionas and PRIMACYT said today that they will jointly develop a cell-based assay using human liver cells to predict hepatotoxic effects of drugs and chemicals.
 
PRIMACYT, based in Schwerin, Germany, will supply the hepatocytes. The hepatocytes will be cultivated on Bionas metabolic chips with chemically defined media from PRIMACYT.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.